Evolva expands collaboration with IFF
Evolva Holding SA announced that it has expanded its collaboration with International flavors & Fragrances Inc. Evolva has been working with IFF since early 2011 to implement a commercially viable biosynthetic route for the sustainable production of a key flavouring ingredient. This project is progressing on schedule. The collaboration is now expanded to include an additional flavouring ingredient.
Under the four year agreement, IFF will fund research and development activities at Evolva, focused primarily on pathway discovery and yield stages of the programme through the scale-up and manufacturing phases. Evolva will receive an upfront payment as well as monthly research fees. Furthermore, Evolva will receive royalty on product sales based on both margin and volume.
Neil Goldsmith, CEO of Evolva, said “Our first project with IFF is progressing well and we are excited about extending the collaboration. It is clear our biosynthesis platform is delivering radically new products and processes. These have the potential to open up markets that were previously constrained by cost, production or supply chain factors.”
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
